ArticleEuropean journal of nuclear medicine and molecular imaging2025

Personalized baseline and residual TMTV influence treatment response and outcomes in relapsed/refractory lymphomas: results from the GATA study.

Solène Malmon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.